Web based Drug Database (1.07 Linux)

BUDESONIDE [INHALED]

Names
Common Name	BUDESONIDE [INHALED]
Other Name	BUDESONIDE [INHALED]
Pharmacological Group	CORTICOSTEROIDS
Chemical Name	An epimeric mixture of the alpha- and beta-propyl forms of 16alpha,17alpha-butylidenedioxy-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
Chemical Group

Attributes

Indications	Contraindications	Prescriber Cautions	Patient Cautions
Toxicity	Side Effects	Liver Disease	Renal Failure
Pregnancy	Lactation	Pharmacological Actions	Diagnostic Procedures
Drugs	Interactions

Indications

Wheezing
Croup
Chronic asthmatic bronchitis
Asthma
Airways obstruction reversible
Paediatric use

Contraindications

Adverse reaction to adrenal cortical steroids

Prescriber Cautions

Not for infants under 5
CSM/CHM advises using the lowest effective dosage of BUDESONIDE [INHALED] to minimise side effects
To avoid confusion between different formulations of BUDESONIDE [INHALED], prescribers should specify the brand to be dispensed

Patient Cautions

See information on products containing BUDESONIDE [INHALED] for specific advice for patients

Toxicity

- None Listed -

Side Effects

Candidiasis mouth/oesophagus/gastrointestinal tract - Common
Difficulty swallowing solids - Common
Dry cough - Common
Hoarseness - Common
Sore mouth - Common
Anaphylactic shock - Rare
Angioneurotic oedema - Rare
Bronchospasm - Rare
Erythema - Rare
Growth retardation in children - Rare
Itching - Rare
Rash - Rare
Spontaneous bruising - Rare
Behavioural disturbance - Very Rare
Bone densimetry abnormal - Very Rare
Cataract - Very Rare
Cushing's syndrome - Very Rare
Depression - Very Rare
Hyperactive behaviour - Very Rare
Nervousness - Very Rare
Restlessness - Very Rare
Steroid facies - Very Rare
Steroid-induced glaucoma - Very Rare

Liver Disease

Liver disease may alter the response to drugs in several ways. Prescribing should be kept to a minimum in all patients with severe liver disease, especially if jaundice, ascites, or evidence of encephalopathy present

Renal Failure

Consider dose reduction in renal failure to avoid possibility of toxicity, increased sensitivity, and side effects

Pregnancy

Benefits of treatment outweigh risk

Lactation

BUDESONIDE [INHALED] excreted in low concentration in breast milk
BUDESONIDE [INHALED] appears safe in breast feeding

Pharmacological Actions

CORTICOSTEROID effect
GLUCOCORTICOID effect

Diagnostic Procedures

Serum total estrogen low
Urine total estrogen low
Blood urea high
Creatine kinase high
Serum triglycerides high
Serum glucose high

Drugs containing BUDESONIDE [INHALED]

PULMICORT LS 50mcg inhaler
PULMICORT 200mcg turbo 100dose
PULMICORT 400mcg turbo 50dose
BUDESONIDE 50mcg spacer inh
PULMICORT LS 50mcg spacer inh
BUDESONIDE 200mcg cart refill
NOVOLIZER 200mcg refill cart
EASYHALER BUDESONID 100mcg inh
EASYHALER BUDESONID 200mcg inh
EASYHALER BUDESONID 400mcg inh
PULMICORT 100mcg CFC-free inh
BUDESONIDE 100mcg CFC-free inh
PULMICORT 200mcg CFC-free inh
BUDESONIDE 200mcg CFC-free inh
PULMICORT 500mcg Respules 2mL
PULMICORT 1mg Respules 2mL
PULMICORT 100mcg turbo 200dose
BUDESONIDE 100mcg bth-act inh
BUDESONIDE 200mcg bth-act inh
BUDESONIDE 400mcg bth-act inh
BUDESONIDE 500mcg/2mL neb.soln
BUDESONIDE 1mg/2mL neb.soln
NOVOLIZR BUDES 200mcg cart+inh
BUDESONDE 200mcg/dose cart+inh
BUDESONIDE 50microgram inhaler
SYMBICORT 100/6 Turbohaler
SYMBICORT 200/6 Turbohaler
SYMBICORT 400/12 Turbohaler
BUDES+FORMOTER 400/12mcg inh
BUDES+FORMOTEROL 200/6mcg inh
BUDES+FORMOTEROL 100/6mcg inh
Budes neb soln 500mcg/2mL 20 A
Budeso nebu 1mg/2ml 20 Almu

Interacting Ingredients

ACEBUTOLOL
Infrequent reports of ACEBUTOLOL reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Potential risk. Avoid
ACECLOFENAC
Infrequent reports of ACECLOFENAC reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
ACEMETACIN
Infrequent reports of ACEMETACIN reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
ATENOLOL [ORAL]
Infrequent reports of ATENOLOL [ORAL] reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Potential risk. Avoid
ATENOLOL [PARENTERAL]
Infrequent reports of ATENOLOL [PARENTERAL] reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Potential risk. Avoid
AZAPROPAZONE
Infrequent reports of AZAPROPAZONE reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
BENZYDAMINE HYDROCHLORIDE
Infrequent reports of BENZYDAMINE HYDROCHLORIDE reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
BETAXOLOL
Infrequent reports of BETAXOLOL reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Potential risk. Avoid
BETAXOLOL [EYE]
Infrequent reports of BETAXOLOL [EYE] reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Potential risk. Avoid
BISOPROLOL FUMARATE
Infrequent reports of BISOPROLOL FUMARATE reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Potential risk. Avoid
CARTEOLOL HYDROCHLORIDE
Infrequent reports of CARTEOLOL HYDROCHLORIDE reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. High risk. Avoid
CARTEOLOL HYDROCHLORIDE [EYE]
Infrequent reports of CARTEOLOL HYDROCHLORIDE [EYE] reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. High risk. Avoid
CARVEDILOL
Infrequent reports of CARVEDILOL reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. High risk. Avoid
CELIPROLOL HYDROCHLORIDE
Infrequent reports of CELIPROLOL HYDROCHLORIDE reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Potential risk. Avoid
DEXIBUPROFEN
Infrequent reports of DEXIBUPROFEN reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
DEXKETOPROFEN
Infrequent reports of DEXKETOPROFEN reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
DICLOFENAC POTASSIUM
Infrequent reports of DICLOFENAC POTASSIUM reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
DICLOFENAC SODIUM [ORAL]
Infrequent reports of DICLOFENAC SODIUM [ORAL] reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
DICLOFENAC SODIUM [PARENTERAL]
Infrequent reports of DICLOFENAC SODIUM [PARENTERAL] reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
DICLOFENAC SODIUM [RECTUM]
Infrequent reports of DICLOFENAC SODIUM [RECTUM] reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
DIFLUNISAL
Infrequent reports of DIFLUNISAL reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
ESMOLOL HYDROCHLORIDE
Infrequent reports of ESMOLOL HYDROCHLORIDE reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Potential risk. Avoid
ETODOLAC
Infrequent reports of ETODOLAC reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
FELBINAC
Infrequent reports of FELBINAC reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
FENOPROFEN
Infrequent reports of FENOPROFEN reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
FLURBIPROFEN
Infrequent reports of FLURBIPROFEN reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
FLURBIPROFEN [RECTUM]
Infrequent reports of FLURBIPROFEN [RECTUM] reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
IBUPROFEN
Infrequent reports of IBUPROFEN reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
IBUPROFEN LYSINE
Infrequent reports of IBUPROFEN LYSINE reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
INDOMETACIN
Infrequent reports of INDOMETACIN reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
INDOMETACIN [RECTUM]
Infrequent reports of INDOMETACIN [RECTUM] reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
KETOPROFEN
Infrequent reports of KETOPROFEN reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
KETOPROFEN [RECTUM]
Infrequent reports of KETOPROFEN [RECTUM] reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
KETOROLAC TROMETAMOL
Likely interaction of KETOROLAC TROMETAMOL reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. High risk. May need to avoid combination
KETOROLAC TROMETAMOL [EYE]
Likely interaction of KETOROLAC TROMETAMOL [EYE] reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. High risk. May need to avoid combination
LABETALOL HYDROCHLORIDE
Infrequent reports of LABETALOL HYDROCHLORIDE reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. High risk. Avoid
LEVOBUNOLOL [EYE]
Infrequent reports of LEVOBUNOLOL [EYE] reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. High risk. Avoid
MEFENAMIC ACID
Infrequent reports of MEFENAMIC ACID reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
MELOXICAM
Infrequent reports of MELOXICAM reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
MELOXICAM [RECTUM]
Infrequent reports of MELOXICAM [RECTUM] reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
METIPRANOLOL [EYE]
Infrequent reports of METIPRANOLOL [EYE] reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. High risk. Avoid
METOPROLOL FUMARATE
Infrequent reports of METOPROLOL FUMARATE reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Potential risk. Avoid
METOPROLOL TARTRATE
Infrequent reports of METOPROLOL TARTRATE reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Potential risk. Avoid
NABUMETONE
Infrequent reports of NABUMETONE reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
NADOLOL
Infrequent reports of NADOLOL reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. High risk. Avoid
NAPROXEN
Infrequent reports of NAPROXEN reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
NAPROXEN SODIUM
Infrequent reports of NAPROXEN SODIUM reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
NAPROXEN [RECTUM]
Infrequent reports of NAPROXEN [RECTUM] reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
NATEGLINIDE
Likely interaction of BUDESONIDE [INHALED] reducing the HYPOGLYCAEMIC effect of NATEGLINIDE. Potential risk. Monitor
NEFOPAM HYDROCHLORIDE
Infrequent reports of NEFOPAM HYDROCHLORIDE reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
OXPRENOLOL HYDROCHLORIDE
Infrequent reports of OXPRENOLOL HYDROCHLORIDE reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. High risk. Avoid
PENBUTOLOL SULPHATE
Infrequent reports of PENBUTOLOL SULPHATE reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. High risk. Avoid
PHENYLBUTAZONE
Infrequent reports of PHENYLBUTAZONE reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
PINDOLOL
Infrequent reports of PINDOLOL reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. High risk. Avoid
PIROXICAM
Infrequent reports of PIROXICAM reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
PIROXICAM [RECTUM]
Infrequent reports of PIROXICAM [RECTUM] reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
PIROXICAM-BETADEX
Infrequent reports of PIROXICAM-BETADEX reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
PRACTOLOL
Infrequent reports of PRACTOLOL reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Potential risk. Avoid
PROPAFENONE HYDROCHLORIDE
Infrequent reports of PROPAFENONE HYDROCHLORIDE reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. May need to avoid combination
PROPRANOLOL HYDROCHLORIDE
Infrequent reports of PROPRANOLOL HYDROCHLORIDE reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. High risk. Avoid
SOTALOL HYDROCHLORIDE
Infrequent reports of SOTALOL HYDROCHLORIDE reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. High risk. Avoid
SULINDAC
Infrequent reports of SULINDAC reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
TENOXICAM
Infrequent reports of TENOXICAM reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
TIAPROFENIC ACID
Infrequent reports of TIAPROFENIC ACID reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
TIMOLOL
Infrequent reports of TIMOLOL reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. High risk. Avoid
TIMOLOL [EYE]
Infrequent reports of TIMOLOL [EYE] reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. High risk. Avoid
TOLFENAMIC ACID
Infrequent reports of TOLFENAMIC ACID reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
TOLMETIN
Infrequent reports of TOLMETIN reducing the BRONCHODILATOR effect of BUDESONIDE [INHALED]. Moderate risk. Avoid
XAMOTEROL FUMARATE
Infrequent reports of BUDESONIDE [INHALED] increasing the BRONCHOCONSTRICTOR effect of XAMOTEROL FUMARATE. Moderate risk. Monitor